J. Randolph Hecht, MD is a Professor of Clinical Medicine in the David Geffen School of Medicine at UCLA School of Medicine. He holds the Carol and Saul Rosenzweig Chair for Cancer Therapies Development and is the Director of the UCLA Gastrointestinal Oncology Program. Dr. Hecht graduated from Eastern Virginia Medical School and took his internal medicine residency at Northwestern and completed fellowships in gastroenterology research at the University of Chicago, and in gastroenterology and medical oncology at UCLA. He is the director of the UCLA GI Oncology Program which has one of the largest clinical and research programs in the Western United States.
Dr. Hecht is an internationally known clinical and translational researcher who has published widely in the field of gastrointestinal cancers. He has run multiple phase II and phase III trials with targeted therapies and immunotherapy. Dr. Hecht is currently leading national and international multicenter trials with novel immune and CAR-T therapies.
